As of June 21, 2025, Yantai Dongcheng Biochemicals Co Ltd (002675.SZ) reports a Net Margin of 6.41%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Yantai Dongcheng Biochemicals Co Ltd's Net Margin
Over recent years, Yantai Dongcheng Biochemicals Co Ltd's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 6.41% |
| 2023-12-31 | 6.40% |
| 2022-12-31 | 8.58% |
| 2021-12-31 | 3.87% |
| 2020-12-31 | 12.22% |
This slight upward trend highlights how Yantai Dongcheng Biochemicals Co Ltd manages its overall profitability and cost control over time.
Comparing Yantai Dongcheng Biochemicals Co Ltd's Net Margin to Peers
To better understand Yantai Dongcheng Biochemicals Co Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Yantai Dongcheng Biochemicals Co Ltd (002675.SZ) | 6.41% |
| Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336.SS) | 59.03% |
| Beijing Strong Biotechnologies Inc (300406.SZ) | 32.11% |
| Xiamen Amoytop Biotech Co Ltd (688278.SS) | 29.38% |
| Beijing Balance Medical Technology Co Ltd (688198.SS) | 29.16% |
| Anhui Anke Biotechnology Group Co Ltd (300009.SZ) | 27.88% |
Compared to its competitors, Yantai Dongcheng Biochemicals Co Ltd's Net Margin is about average compared to peers, reflecting typical industry profitability.